Cargando…

Pharmacist Prescriptive Authority: Lessons from Idaho

Pharmacist prescriptive authority continues to increase at the state level in the United States. Recently, the Idaho Board of Pharmacy (BOP) finalized regulations that expanded autonomous prescriptive authority in its state to a range of preventative care as well as acute and chronic conditions. Thi...

Descripción completa

Detalles Bibliográficos
Autor principal: Adams, Alex J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559090/
https://www.ncbi.nlm.nih.gov/pubmed/32650367
http://dx.doi.org/10.3390/pharmacy8030112
_version_ 1783594781592518656
author Adams, Alex J.
author_facet Adams, Alex J.
author_sort Adams, Alex J.
collection PubMed
description Pharmacist prescriptive authority continues to increase at the state level in the United States. Recently, the Idaho Board of Pharmacy (BOP) finalized regulations that expanded autonomous prescriptive authority in its state to a range of preventative care as well as acute and chronic conditions. This manuscript reviews the key decision points made by the BOP regarding drug categories included, education requirements, protocols, access to data, and use of standards of care. Overall, Idaho’s approach closely reflects the medical model of regulation and may prove useful to other states and jurisdictions as they consider similar issues.
format Online
Article
Text
id pubmed-7559090
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75590902020-10-29 Pharmacist Prescriptive Authority: Lessons from Idaho Adams, Alex J. Pharmacy (Basel) Letter Pharmacist prescriptive authority continues to increase at the state level in the United States. Recently, the Idaho Board of Pharmacy (BOP) finalized regulations that expanded autonomous prescriptive authority in its state to a range of preventative care as well as acute and chronic conditions. This manuscript reviews the key decision points made by the BOP regarding drug categories included, education requirements, protocols, access to data, and use of standards of care. Overall, Idaho’s approach closely reflects the medical model of regulation and may prove useful to other states and jurisdictions as they consider similar issues. MDPI 2020-07-08 /pmc/articles/PMC7559090/ /pubmed/32650367 http://dx.doi.org/10.3390/pharmacy8030112 Text en © 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Letter
Adams, Alex J.
Pharmacist Prescriptive Authority: Lessons from Idaho
title Pharmacist Prescriptive Authority: Lessons from Idaho
title_full Pharmacist Prescriptive Authority: Lessons from Idaho
title_fullStr Pharmacist Prescriptive Authority: Lessons from Idaho
title_full_unstemmed Pharmacist Prescriptive Authority: Lessons from Idaho
title_short Pharmacist Prescriptive Authority: Lessons from Idaho
title_sort pharmacist prescriptive authority: lessons from idaho
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559090/
https://www.ncbi.nlm.nih.gov/pubmed/32650367
http://dx.doi.org/10.3390/pharmacy8030112
work_keys_str_mv AT adamsalexj pharmacistprescriptiveauthoritylessonsfromidaho